|
PARG expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.405700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.734200E-02 |
| Normal-vs-Stage2 |
7.878000E-01 |
| Normal-vs-Stage3 |
4.346400E-01 |
| Normal-vs-Stage4 |
1.445780E-01 |
| Stage1-vs-Stage2 |
4.563400E-01 |
| Stage1-vs-Stage3 |
5.754800E-01 |
| Stage1-vs-Stage4 |
5.199200E-01 |
| Stage2-vs-Stage3 |
7.566400E-01 |
| Stage2-vs-Stage4 |
3.613400E-01 |
| Stage3-vs-Stage4 |
4.477800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.626000E-02 |
| Normal-vs-AfricanAmerican |
5.147800E-01 |
| Normal-vs-Asian |
3.343400E-01 |
| Caucasian-vs-AfricanAmerican |
2.251800E-01 |
| Caucasian-vs-Asian |
9.685600E-01 |
| AfricanAmerican-vs-Asian |
7.225200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.372040E-02 |
| Normal-vs-Female |
6.889000E-01 |
| Male-vs-Female |
5.117600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.506000E-02 |
| Normal-vs-Extreme_Weight |
4.198300E-03 |
| Normal-vs-Obese |
3.754400E-01 |
| Normal-vs-Extreme_Obese |
5.221400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.504000E-01 |
| Normal_Weight-vs-Obese |
1.492830E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.346600E-01 |
| Extreme_Weight-vs-Obese |
6.694100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.600600E-01 |
| Obese-vs-Extreme_Obese |
8.380000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.800000E-02 |
| Normal-vs-Age(41-60Yrs) |
6.014200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.365950E-02 |
| Normal-vs-Age(81-100Yrs) |
3.012800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.094200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.618200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.871950E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.216100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.557320E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.105390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.430200E-01 |
| Normal-VS-Type2 PRCC |
7.102000E-03 |
| Normal-VS-KIRP CIMP |
1.288070E-02 |
| Normal-VS-Unclassified PRCC |
8.066800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.192300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.923990E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.742400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.120400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.714200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.217900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.731800E-02 |
| Normal-vs-N1 |
9.378400E-01 |
| Normal-vs-N2 |
4.531700E-02 |
| N0-vs-N1 |
1.912820E-01 |
| N0-vs-N2 |
5.895800E-01 |
| N1-vs-N2 |
3.188800E-01 |
|
|
